Stuart Bloor

6.9k total citations · 2 hit papers
49 papers, 4.7k citations indexed

About

Stuart Bloor is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Stuart Bloor has authored 49 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 30 papers in Virology and 14 papers in Molecular Biology. Recurrent topics in Stuart Bloor's work include HIV Research and Treatment (30 papers), HIV/AIDS drug development and treatment (28 papers) and HIV/AIDS Research and Interventions (18 papers). Stuart Bloor is often cited by papers focused on HIV Research and Treatment (30 papers), HIV/AIDS drug development and treatment (28 papers) and HIV/AIDS Research and Interventions (18 papers). Stuart Bloor collaborates with scholars based in United Kingdom, United States and Germany. Stuart Bloor's co-authors include Felix Randow, Brendan Larder, Natalia von Muhlinen, Teresa L. M. Thurston, Kurt Hertogs, Grigory Ryzhakov, Sharon D. Kemp, Veronica Miller, David Komander and P. Richard Harrigan and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Stuart Bloor

49 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria

2009 694 citations Teresa L. M. Thurston, Grigory Ryzhakov et al. Nature Immunology profile →
Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation

2009 595 citations Masato Akutsu, Stuart Bloor et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart Bloor United Kingdom	35	2.3k	2.3k	1.5k	1.3k	653	49	4.7k
Glenn Randall United States	36	1.2k 0.5×	667 0.3×	2.6k 1.8×	2.4k 1.8×	1.1k 1.7×	66	6.9k
Kara G. Lassen United States	26	1.1k 0.5×	1.9k 0.8×	1.2k 0.8×	845 0.6×	1.3k 2.0×	36	3.4k
Pierre‐Olivier Vidalain France	38	1.2k 0.5×	422 0.2×	1.5k 1.0×	1.4k 1.0×	1.4k 2.1×	102	4.1k
Felipe Diaz‐Griffero United States	48	2.0k 0.9×	4.5k 2.0×	2.6k 1.8×	1.8k 1.4×	2.8k 4.3×	120	6.7k
Amy S. Espeseth United States	30	2.5k 1.1×	2.5k 1.1×	2.3k 1.6×	945 0.7×	599 0.9×	59	4.8k
Ju‐Tao Guo United States	53	2.4k 1.0×	793 0.3×	1.8k 1.2×	5.3k 3.9×	2.0k 3.0×	120	8.3k
Xiaoyun Wu United States	29	2.1k 0.9×	3.7k 1.6×	2.4k 1.7×	1.1k 0.8×	1.8k 2.8×	51	6.1k
Marlène Dreux France	32	694 0.3×	425 0.2×	1.2k 0.8×	2.6k 1.9×	655 1.0×	51	4.8k
Jinhong Chang United States	44	1.5k 0.6×	445 0.2×	1.9k 1.3×	2.5k 1.9×	1.4k 2.1×	103	5.5k
Kirsten M. Stray United States	18	1.3k 0.6×	1.6k 0.7×	1.2k 0.9×	623 0.5×	380 0.6×	25	3.1k

Countries citing papers authored by Stuart Bloor

Since Specialization

Citations

This map shows the geographic impact of Stuart Bloor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Bloor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Bloor more than expected).

Fields of papers citing papers by Stuart Bloor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Bloor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Bloor. The network helps show where Stuart Bloor may publish in the future.

Co-authorship network of co-authors of Stuart Bloor

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Bloor. A scholar is included among the top collaborators of Stuart Bloor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Bloor. Stuart Bloor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bloor, Stuart, et al.. (2024). RNA binding by Periphilin plays an essential role in initiating silencing by the HUSH complex. Nucleic Acids Research. 53(2). 2 indexed citations

Juillard, Franceline, Armelle Corpet, Olivier Binda, et al.. (2024). The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes. Proceedings of the National Academy of Sciences. 121(49). e2412258121–e2412258121. 1 indexed citations

Williams, Thomas, Maria Colzani, Robyn Macrae, et al.. (2021). Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection. Communications Biology. 4(1). 926–926. 11 indexed citations

Thurston, Teresa L. M., Keith B. Boyle, Mark D. Allen, et al.. (2016). Recruitment of TBK 1 to cytosol‐invading Salmonella induces WIPI 2‐dependent antibacterial autophagy. The EMBO Journal. 35(16). 1779–1792. 96 indexed citations

Sarhadi, Virinder Kaur, Mikko Rönty, Kaisa Salmenkivi, et al.. (2013). Targeted Resequencing RevealsALKFusions in Non-Small Cell Lung Carcinomas Detected by FISH, Immunohistochemistry, and Real-Time RT-PCR: A Comparison of Four Methods. BioMed Research International. 2013. 1–9. 41 indexed citations

Muhlinen, Natalia von, Masato Akutsu, Benjamin J. Ravenhill, et al.. (2012). LC3C, Bound Selectively by a Noncanonical LIR Motif in NDP52, Is Required for Antibacterial Autophagy. Molecular Cell. 48(3). 329–342. 260 indexed citations

Bloor, Stuart, et al.. (2010). Endoplasmic reticulum chaperone gp96 is essential for infection with vesicular stomatitis virus. Proceedings of the National Academy of Sciences. 107(15). 6970–6975. 37 indexed citations

Thurston, Teresa L. M., Grigory Ryzhakov, Stuart Bloor, Natalia von Muhlinen, & Felix Randow. (2009). The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nature Immunology. 10(11). 1215–1221. 694 indexed citations breakdown →

Romanó, Laura, Giulietta Venturi, Stuart Bloor, et al.. (2002). Broad Nucleoside‐Analogue Resistance Implications for Human Immunodeficiency Virus Type 1 Reverse‐Transcriptase Mutations at Codons 44 and 118. The Journal of Infectious Diseases. 185(7). 898–904. 44 indexed citations

10.

Weidle, Paul J., Cissy Kityo, Peter Mugyenyi, et al.. (2001). Resistance to Antiretroviral Therapy Among Patients in Uganda. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(5). 495–500. 16 indexed citations

11.

Wegner, Scott A., Stephanie K. Brodine, John R. Mascola, et al.. (2000). Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel. AIDS. 14(8). 1009–1015. 101 indexed citations

12.

Miller, Veronica, Alessandro Cozzi‐Lepri, Kurt Hertogs, et al.. (2000). HIV Drug Susceptibility and Treatment Response to Mega-Haart Regimen in Patients from the Frankfurt HIV Cohort. Antiviral Therapy. 5(1). 49–55. 65 indexed citations

13.

Larder, Brendan, et al.. (2000). Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples. AIDS. 14(13). 1943–1948. 112 indexed citations

14.

Casado, José L., Kurt Hertogs, Lı́dia Ruiz, et al.. (2000). Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen. AIDS. 14(2). F1–F7. 79 indexed citations

15.

Miller, Veronica, Caroline Sabin, Kurt Hertogs, et al.. (2000). Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure. AIDS. 14(18). 2857–2867. 165 indexed citations

16.

Hertogs, Kurt, Stuart Bloor, Sharon D. Kemp, et al.. (2000). Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples. AIDS. 14(9). 1203–1210. 157 indexed citations

17.

Churchill, Duncan, Alexander S. Pym, S. Galpin, et al.. (1999). The Rabbit Study: Ritonavir and Saquinavir in Combination in Saquinavir-Experienced and Previously Untreated Patients. AIDS Research and Human Retroviruses. 15(13). 1181–1189. 5 indexed citations

18.

Harrigan, P. Richard, Kurt Hertogs, Werner Verbiest, et al.. (1999). Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting. AIDS. 13(14). 1863–1871. 101 indexed citations

19.

Miller, Veronica, Andrew Phillips, Schlomo Staszewski, et al.. (1998). Dual Resistance to Zidovudine and Lamivudine in Patients Treated with Zidovudine‐Lamivudine Combination Therapy: Association with Therapy Failure. The Journal of Infectious Diseases. 177(6). 1521–1532. 74 indexed citations

20.

Larder, Brendan, Arinder Kohli, Stuart Bloor, et al.. (1996). Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group. Journal of Virology. 70(9). 5922–5929. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact